CPI-1189 is primarily investigated for its potential neuroprotective properties, particularly in the context of neurodegenerative diseases such as Alzheimer's disease. It functions as a modulator of cellular signaling pathways involved in inflammation and neuronal survival. By inhibiting specific kinases and reducing the production of pro-inflammatory cytokines, CPI-1189 helps mitigate neuroinflammation, a key contributor to neuronal damage in chronic brain disorders. It has also shown potential in promoting the survival of neurons under stress conditions, making it a candidate for research in stroke and other acute neurological injuries. While still in experimental stages, its ability to cross the blood-brain barrier enhances its suitability for central nervous system-targeted therapies.